Pilot and Feasibility Funding Opportunity for Diabetes Translation Research
The Vanderbilt Center for Diabetes Translation Research (CDTR) has funds available (up to $35,000 per year for two years) to support pilot studies in translational research in the area of diabetes or obesity beginning Sept. 1.
The aim of the Vanderbilt Center for Diabetes Translation Research is to improve prevention and treatment of diabetes by promoting research that supports rapid dissemination, implementation and sustained use of effective interventions/approaches.
These funds are intended for new investigators with an interest in a career in diabetes or obesity research, for investigators from other fields willing to bring their research expertise to diabetes- or obesity-relevant research, for investigators currently in the diabetes area whose proposed research constitutes a new direction, or for clinical and translational researchers who propose a joint research project. The center seeks to support type II translation research.
The NIDDK definition defines type II translational research (e.g. bedside to practice and the community) as testing innovative adaptations of evidence-based approaches to prevent and treat diabetes that can be disseminated and sustained in clinical health care practice and other settings outside of the traditional academic research setting.
The CDTR continues a collaborative relationship with the Vanderbilt Diabetes Research and Training Center in the pursuit of translational research. This funding opportunity is, however, distinct from those of the Vanderbilt Diabetes Research and Training Center.
Application deadline is 4 p.m., Tuesday, May 1.
Application forms and detailed instructions can be obtained from the DRTC P&F website: